Opportunity speculation can be captured in a spreadsheet, however, the path to commercial viability is determined in the real world by users, payers, clinicians and physicians. And while a good pitch is necessary to create interest for investment, it is validating the path to commercial viability that secures the investment.
RQR PARTNERS™ offers direct funding for early stage companies based on commercial viability, strategic partners and liquidation time horizon. In addition, we advise entrepreneurs on potential sources of non-dilutive funding.
We lead life science entrepreneurs with a holistic view of their business, using comprehensive real market knowledge, behind-the-scenes access and unique funding sources to attain commercial viability.